First -- The Authorized Shares (AS) is what was going to be reduced... not the Outstanding Shares (OS). That valuation post was derived from taking under consideration the OS, not the AS. The AS is not the denominator that's used to derive an Earnings Per Share that's used to help derive where a stock should be trading after taking into consideration its Price to Earnings (P/E) Ratio for the Industry in which it would trade.
Second -- I also mentioned in that post and within a latter post concerning that particular valuation perspective that for any future changes to any of the variables in relation to that valuation post (or actually any valuation that I might make), use the Substitution Property accordingly to derive the value of where MRIB should fundamentally trade if their operational goals are achieved.
Example:
I used an OS of 408,259,529 shares. The OS from recently confirmed by some a couple of days ago or so is actually 418,259,529 shares. Simply take that amount and replace it with the old amount within the post below to get a new valuation to consider for MRIB: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=94415228
Hopefully if you have done that, you will see that MRIB is still significantly undervalued and is still worth somewhere north of .12+ per share per year over the next 5 years if they achieve their ”minimum” operational goals just based of this recently announced $40 Million Distribution Contract with Brazil.
Market Data 
Markets 
AI
